Literature DB >> 15150074

Histone H1-like protein participates in endothelial cell-specific activation of the von Willebrand factor promoter.

Xinyu Wang1, Yiwen Peng, Yuliang Ma, Nadia Jahroudi.   

Abstract

A region of the von Willebrand factor (VWF) promoter has been identified that is necessary to confer endothelial cell-specific activation to the VWF promoter. This region spans sequences +155 to +247 and contains binding sites for GATA6 and NFY transcription factors. To identify potential DNA binding transcription factors that directly interact with these sequences in an endothelial-specific manner, we have performed extensive gel mobility assays with use of 7 overlapping DNA probes that collectively span this entire region. An endothelial-specific protein DNA complex was formed with an oligonucleotide that corresponded to sequences +155 to +184 of the VWF gene. Mutation analysis identified a 6-nucleotide element corresponding to sequences +164 to +169 as the core-binding region for the formation of this complex. Transfection analysis demonstrated that the mutation, which abolished DNA-protein interaction, resulted in significant inhibition of the VWF promoter activity. DNA pull-down analysis, mass spectrometry, and Western blot analysis demonstrated that a 32-kDa polypeptide with homology to histone H1 constituted the endothelial-specific DNA binding protein, or a DNA binding subunit of this protein complex. On the basis of these results, we hypothesize that an H1-like protein functions as an endothelial cell-specific transcriptional activator of the VWF promoter.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150074     DOI: 10.1182/blood-2004-01-0082

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Repressors NFI and NFY participate in organ-specific regulation of von Willebrand factor promoter activity in transgenic mice.

Authors:  Marjan Nassiri; Ju Liu; Stephen Kulak; Richard R E Uwiera; William C Aird; Barbara J Ballermann; Nadia Jahroudi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-29       Impact factor: 8.311

2.  Diet-induced early-stage atherosclerosis in baboons: Lipoproteins, atherogenesis, and arterial compliance.

Authors:  Michael C Mahaney; Genesio M Karere; David L Rainwater; Venkata S Voruganti; Edward J Dick; Michael A Owston; Karen S Rice; Laura A Cox; Anthony G Comuzzie; John L VandeBerg
Journal:  J Med Primatol       Date:  2017-06-16       Impact factor: 0.667

Review 3.  Regulation of VWF expression, and secretion in health and disease.

Authors:  Yaozu Xiang; John Hwa
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

4.  Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin.

Authors:  Anahita Mojiri; Konstantin Stoletov; Maria Areli Lorenzana Carrillo; Lian Willetts; Saket Jain; Roseline Godbout; Paul Jurasz; Consolato M Sergi; David D Eisenstat; John D Lewis; Nadia Jahroudi
Journal:  Oncotarget       Date:  2017-02-21

5.  Effects of Shear Stress on Production of FVIII and vWF in a Cell-Based Therapeutic for Hemophilia A.

Authors:  Brady Trevisan; Alshaimaa Morsi; Julio Aleman; Martin Rodriguez; Jordan Shields; Diane Meares; Andrew M Farland; Christopher B Doering; H Trent Spencer; Anthony Atala; Aleks Skardal; Christopher D Porada; Graça Almeida-Porada
Journal:  Front Bioeng Biotechnol       Date:  2021-03-01

Review 6.  Inflammation, von Willebrand factor, and ADAMTS13.

Authors:  Junmei Chen; Dominic W Chung
Journal:  Blood       Date:  2018-06-04       Impact factor: 25.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.